Symptom subtypes of obsessive–compulsive disorder: are they relevant for treatment?

References

• van Oppen P, Hoekstra RJ, Emmelkamp PMG. The structure of obsessive-compulsive symptoms. Behav Res Ther 1995; 33: 379–390
   PubMed Web of Science ®Google Scholar
• Kyrios M, Bhar S, Wade D. The assessment of obsessive-compulsive phenomena: psychometric and normative data on the Padua Inventory from an Australian non-clinical sample. Behav Res Ther 1996; 34: 85–95
   PubMed Web of Science ®Google Scholar
• Leckman JF, Grice DE, Boardman J, et al. Symptoms of obsessive-compulsive disorder. Am J Psychiatry 1997; 154: 911–917
   PubMed Web of Science ®Google Scholar
• Calamari JE, Wiegartz RS, Janeck AS. Obsessive-compulsive subgroups: a symptom-based clustering approach. Behav Res Ther 1999; 37: 113–125
   PubMed Web of Science ®Google Scholar
• Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 1999; 156: 1409–1416
   PubMed Web of Science ®Google Scholar
• Summerfeldt LJ, Richter MA, Antony MM, Swinson RP. Symptom structure in obsessive-compulsive disorder: a confirmatory factor-analytic study. Behav Res Ther 1999; 37: 297–311
   PubMed Web of Science ®Google Scholar
• Abramowitz JS, Franklin ME, Schwartz SA, Furr JM. Symptom presentation and outcome of cognitive behavioral therapy for obsessive-compulsive disorder. J Consult Clin Psychol 2003; 71: 1049–1057
   PubMed Web of Science ®Google Scholar
• Feinstein SB, Fallon BA, Petkova E, Liebowitz MR. Item-by-item factor analysis of the Yale-Brown Obsessive Compulsive Scale Symptom Checklist. J Neuropsychiatry Clin Neurosci 2003; 15: 187–193
   PubMed Web of Science ®Google Scholar
• Calamari JE, Wiegartz RS, Riemann BC, et al. Obsessive-compulsive disorder subtypes: an attempted replication and extension of a symptom-based taxonomy. Behav Res Ther 2004; 42: 647–670
   PubMed Web of Science ®Google Scholar
• Denys D, de Geus F, van Megen HJGM, Westenberg HGM. Symptom dimensions in obsessive-compulsive disorder: factor analysis on a clinician-rated scale and a self-report measure. Psychopathol 2004; 37: 181–189
   PubMed Web of Science ®Google Scholar
• Stein DJ, Andersen EW, Overo KF. Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo. Rev Bras Psiquiatr 2007; 29: 303–307
   PubMed Web of Science ®Google Scholar
• Matsunaga H, Maebayashi K, Hayashida K, et al. Symptom structure in Japanese patients with obsessive-compulsive disorder. Am J Psychiatry 2008; 165: 251–253
   PubMed Web of Science ®Google Scholar
• Rasmussen SA, Eisen JL. The epidemiology and clinical features of obsessive-compulsive disorder. Psychiatr Clin North Am 1992; 15: 743–758
   PubMed Web of Science ®Google Scholar
• Mataix-Cols D, Rauch SL, Baer L, et al. Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study. Am J Psychiatry 2002; 159: 263–268
   PubMed Web of Science ®Google Scholar
• Rufer M, Grothusen A, Mass R, Peter H, Hand I. Temporal stability of symptom dimensions in adult patients with obsessive-compulsive disorder. J Affect Disord 2005; 88: 99–102
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence (NICE) Guidelines. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. London: National Institute for Health and Clinical Excellence, 2005.
   Google Scholar
• American Psychiatric Association. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 2007; 164 (Suppl):1–56.
   PubMed Web of Science ®Google Scholar
• Goodman WK, Price LH, Rasmussen SA, et al. The Yale–Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46: 1006–1011
   PubMed Web of Science ®Google Scholar
• Eisen JL, Goodman WK, Keller MB, et al. Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. J Clin Psychiatry 1999; 60: 346–351
   PubMed Web of Science ®Google Scholar
• Schruers K, Koning K, Luermans J, Haack MJ, Griez E. Obsessive-compulsive disorder: a critical review of therapeutic perspectives. Acta Psychiatr Scand 2005; 111: 261–271
   PubMed Web of Science ®Google Scholar
• Ball SG, Baer L, Otto MW. Symptom subtypes of obsessive-compulsive disorder in behavioral treatment studies: a quantitative review. Behav Res Ther 1996; 34: 47–51
   PubMed Web of Science ®Google Scholar
• Mataix-Cols D, Marks IM, Greist JH, Kobak KA, Baer L. Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom 2002; 71: 255–262
   PubMed Web of Science ®Google Scholar
• Rufer M, Fricke S, Moritz S, Kloss M, Hand I. Symptom dimensions in obsessive-compulsive disorder: prediction of cognitive–behavior therapy outcome. Acta Psychiatr Scand 2006; 113: 440–446
   PubMed Web of Science ®Google Scholar
• Black DW, Monahan P, Gable J, Blum N, Clancy G, Baker P. Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder. J Clin Psychiatry 1998; 59: 420–425
   PubMed Web of Science ®Google Scholar
• Christensen H, Hadzi-Pavlovic D, Andrews G, Mattick R. Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol 1987; 55: 701–711
   PubMed Web of Science ®Google Scholar
• Alonso P, Menchon JM, Pifarre J, et al. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry 2001; 62: 535–540
   PubMed Web of Science ®Google Scholar
• Buchanan AW, Meng KS, Marks IM. What predicts improvement and compliance during the behavioral treatment of obsessive compulsive disorder?. Anxiety 1996; 2: 22–27
   PubMedGoogle Scholar
• Basoglu M, Lax T, Kasvikis Y, Marks IM. Predictors of improvement in obsessive-compulsive disorder. J Anxiety Disord 1988; 2: 299–317
   Google Scholar
• Foa EB, Goldstein A. Continuous exposure and complete response prevention of obsessive-compulsive neurosis. Behav Ther 1978; 9: 821–829
   Web of Science ®Google Scholar
• Drummond LM. The treatment of severe, chronic, resistant obsessive-compulsive disorder. An evaluation of an in-patient programme using behavioural psychotherapy in combination with other treatments. Br J Psychiatry 1993; 163: 223–229
   PubMed Web of Science ®Google Scholar
• Winsberg ME, Cassic KS, Koran LM. Hoarding in obsessive-compulsive disorder: a report of 20 cases. J Clin Psychiatry 1999; 60: 591–597
   PubMed Web of Science ®Google Scholar
• Erzegovesi S, Cavallini MC, Cavedini P, Diaferia G, Locatelli M, Bellodi L. Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol 2001; 21: 488–492
   PubMed Web of Science ®Google Scholar
• Shetti CN, Reddy YCJ, Kandavel T, et al. Clinical predictors of drug nonresponse in obsessive-compulsive disorder. J Clin Psychiatry 2005; 66: 1517–1523
   PubMed Web of Science ®Google Scholar
• Saxena S, Brody AL, Maidment KM, Baxter LR. Paroxetine treatment of compulsive hoarding. J Psychiatr Res 2007; 41: 481–487
   PubMed Web of Science ®Google Scholar
• DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S. Clinical predictors of treatment response in obsessive-compulsive disorder: exploratory analyses from multicenter trials of clomipramine. Psychopharmacol Bull 1990; 26: 54–59
   PubMedGoogle Scholar
• Ackerman DL, Greenland S, Bystritsky A, Morgenstern H, Katz RJ. Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine. J Clin Psychopharmacol 1994; 14: 247–254
   PubMed Web of Science ®Google Scholar
• Ackerman DL, Greenland S, Bystritsky A. Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder. J Clin Psychopharmacol 1998; 18: 185–192
   PubMed Web of Science ®Google Scholar
• Denys D, Burger H, van Megen H, de Geus F, Westenberg H. A score for predicting response to pharmacotherapy in obsessive-compulsive disorder. Int Clin Psychopharmacol 2003; 18: 315–322
   PubMed Web of Science ®Google Scholar
• Jenike MA, Baer L, Minichiello WE, Rauch SL, Buttolph ML. Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. Am J Psychiatry 1997; 154: 1261–1264
   PubMed Web of Science ®Google Scholar
• Shavitt RG, Belotto C, Curi M, et al. Clinical features associated with treatment response in obsessive-compulsive disorder. Compr Psychiatry 2006; 47: 276–281
   PubMed Web of Science ®Google Scholar
• Himle JA, Fischer DJ, Van Etten ML, Janeck AS, Hanna GL. Group behavioral therapy for adolescents with tic-related and non-tic-related obsessive-compulsive disorder. Depress Anxiety 2003; 17: 73–77
   PubMed Web of Science ®Google Scholar
• Whittal ML, Thordarson DS, McLean PD. Treatment of obsessive-compulsive disorder: cognitive behavior therapy vs exposure and response prevention. Behav Res Ther 2005; 43: 1559–1576
   PubMed Web of Science ®Google Scholar
• Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G. Predictors of drug treatment response in obsessive-compulsive disorder. J Clin Psychiatry 1995; 56: 368–373
   PubMed Web of Science ®Google Scholar
• Catapano F, Perris F, Masella M, et al. Obsessive-compulsive disorder: a 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors. OCD follow-up study. J Psychiatr Res 2006; 40: 502–510
   PubMed Web of Science ®Google Scholar
• Alarcon RD, Libb JW, Spitler D. A predictive study of obsessive-compulsive disorder response to clomipramine. J Clin Psychopharmacol 1993; 13: 210–213
   PubMed Web of Science ®Google Scholar
• Saxena S, Maidment KM, Vapnik T, et al. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment. J Clin Psychiatry 2002; 63: 21–27
   PubMed Web of Science ®Google Scholar
• Hohagen F, Winkelmann G, Rasche-Rauchle H, et al. Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo: results of a multicentre study. Br J Psychiatry 1998; 35(Suppl)71–78
   Web of Science ®Google Scholar
• Keijsers GPJ, Hoogduin CAL, Schaap CPDR. Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder. Br J Psychiatry 1994; 165: 781–786
   PubMed Web of Science ®Google Scholar
• Franklin ME, Abramowitz JS, Kozak MJ, Levitt JT, Foa EB. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples. J Consult Clin Psychol 2000; 68: 594–602
   PubMed Web of Science ®Google Scholar
• Stein DJ, Montgomery SA, Kasper S, Tanghoj P. Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder. Int Clin Psychopharmacol 2001; 16: 357–361
   PubMed Web of Science ®Google Scholar
• Hollander E, Bienstock CA, Koran LM, et al. Refractory obsessive-compulsive disorder: state-of-the-art treatment. J Clin Psychiatry 2002; 63(Suppl 6)20–29
   PubMed Web of Science ®Google Scholar
• Rosario-Campos MC, Leckman JF, Mercadante MT, et al. Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry 2001; 158: 1899–1903
   PubMed Web of Science ®Google Scholar
• Kozak MJ, Foa EB. Obsessions, overvalued ideas, and delusions in obsessive-compulsive disorder. Behav Res Ther 1994; 32: 343–353
   PubMed Web of Science ®Google Scholar
• Foa EB, Abramowitz JS, Franklin ME, Kozak MJ. Feared consequences, fixity of belief, and treatment outcome in patients with obsessive-compulsive disorder. Behav Ther 1999; 30: 717–724
   Web of Science ®Google Scholar
• Kishore VR, Samar R, Reddy YCJ, Chandrasekhar CR, Thennarasu K. Clinical characteristics and treatment response in poor and good insight obsessive-compulsive disorder. Eur Psychiatry 2004; 19: 202–208
   PubMed Web of Science ®Google Scholar
• Minichiello W, Baer L, Jenike MA. Schizotypal personality disorder: a poor prognostic indicator for behavior therapy in the treatment of obsessive-compulsive disorder. J Anxiety Disord 1987; 1: 273–276
   Google Scholar
• Baer L, Jenike MA, Black DW, Treece C, Rosenfeld R, Greist J. Effects of Axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 862–866
   PubMed Web of Science ®Google Scholar
• Moritz S, Fricke S, Jacobsen D, et al. Positive schizotypal symptoms predict treatment outcome in obsessive-compulsive disorder. Behav Res Ther 2004; 42: 217–227
   PubMed Web of Science ®Google Scholar
• Leonard HL, Swedo SE, Lenane MC, et al. A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Arch Gen Psychiatry 1993; 50: 429–439
   PubMed Web of Science ®Google Scholar
• McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. J Clin Psychopharmacol 1993; 13: 354–358
   PubMed Web of Science ®Google Scholar
• McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 1994; 51: 302–308
   PubMed Web of Science ®Google Scholar
• Foa EB. Failure in treating obsessive-compulsives. Behav Res Ther 1979; 17: 169–176
   PubMed Web of Science ®Google Scholar
• Goodman WK, Price LH, Delgado PL, et al. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: comparison of fluvoxamine and desipramine. Arch Gen Psychiatry 1990; 47: 577–585
   PubMed Web of Science ®Google Scholar
• Overbeek T, Schruers K, Vermetten E, Griez E. Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect. J Clin Psychiatry 2002; 63: 1106–1112
   PubMed Web of Science ®Google Scholar
• Lochner C, Kinnear CJ, Hemmings SMJ, et al. Hoarding in obsessive-compulsive disorder: clinical and genetic correlates. J Clin Psychiatry 2005; 66: 1155–1160
   PubMed Web of Science ®Google Scholar
• Samuels JF, Bienvenu OJ, Pinto A, et al. Hoarding in obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. Behav Res Ther 2007; 45: 673–686
   PubMed Web of Science ®Google Scholar
• Damecour CL, Charron M. Hoarding: a symptom, not a syndrome. J Clin Psychiatry 1998; 59: 267–272
   PubMed Web of Science ®Google Scholar
• Frost RO, Steketee G, Williams LF, Warren R. Mood, personality disorder symptoms and disability in obsessive-compulsive hoarders: a comparison with clinical and nonclinical controls. Behav Res Ther 2000; 38: 1071–1081
   PubMed Web of Science ®Google Scholar
• Steketee G, Frost RO. Compulsive hoarding and acquiring: therapist guide. Oxford University Press, Oxford 2006
   Google Scholar
• Hollander E, Rossi NB, Sood E, Pallanti S. Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. Int J Neuropsychopharmacol 2003; 6: 397–401
   PubMed Web of Science ®Google Scholar
• McDougle CJ, Goodman WK, Price LH, Delgado PL, Krystal JH, Charney DS. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry 1990; 147: 652–654
   PubMed Web of Science ®Google Scholar
• Bogetto F, Bellino S, Vaschetto P, Ziero S. Olanzapine augmentation in fluvoxamine-refractory obsessive-compulsive disorder: a 12-week open trial. Psychiatry Res 2000; 96: 91–98
   PubMed Web of Science ®Google Scholar
• Stein DJ, Seedat S, Potocnik F. Hoarding: a review. Isr J Psychiatry Relat Sci 1999; 36: 35–46
   PubMed Web of Science ®Google Scholar
• Freeston MH, Rhéaume J, Ladouceur R. Correcting faulty appraisals of obsessional thoughts. Behav Res Ther 1996; 34: 433–446
   PubMed Web of Science ®Google Scholar
• Obsessive Compulsive Cognitions Working Group. Cognitive assessment of obsessive-compulsive disorder. Behav Res Ther 1997; 35:667–681.
   PubMed Web of Science ®Google Scholar
• Shafran R, Thordarson DS, Rachman S. Thought–action fusion in obsessive-compulsive disorder. J Anxiety Disord 1996; 10: 379–391
   Web of Science ®Google Scholar
• Rachman S. The treatment of obsessions. Oxford University Press, Oxford 2003
   Google Scholar
• Freeston MH, Ladouceur R, Gagnon F, et al. Cognitive-behavioral treatment of obsessive thoughts: a controlled study. J Consult Clin Psychol 1997; 65: 405–413
   PubMed Web of Science ®Google Scholar
• O'Connor K, Freeston MH, Gareau D, et al. Group versus individual treatment in obsessions without compulsions. Clin Psychol Psychother 2005; 12: 87–96
   Web of Science ®Google Scholar
• Mayerovitch JI, du Fort GG, Kakuma R, Bland RC, Newman SC, Pinard G. Treatment seeking for obsessive-compulsive disorder: role of obsessive-compulsive disorder symptoms and comorbid psychiatric diagnoses. Compr Psychiatry 2003; 44: 162–168
   PubMed Web of Science ®Google Scholar
• Eisen JL, Coles ME, Shea TT, et al. Clarifying the convergence between obsessive-compulsive personality disorder criteria and obsessive-compulsive disorder. J Pers Disord 2006; 20: 294–305
   PubMed Web of Science ®Google Scholar
• Sobin C, Blundell ML, Karayiorgou M. Phenotypic differences in early- and late-onset obsessive-compulsive disorder. Compr Psychiatry 2000; 41: 373–379
   PubMed Web of Science ®Google Scholar
• Tükel R, Ertekin E, Batmaz S, et al. Influence of age of onset on clinical features in obsessive-compulsive disorder. Depress Anxiety 2005; 21: 112–117
   PubMed Web of Science ®Google Scholar
• Baer L. Factor analysis of symptom subtypes of obsessive-compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 1994; 55(Suppl 3)18–23
   PubMed Web of Science ®Google Scholar
• Leckman JF, Walker DE, Goodman WK, Pauls DL, Cohen DJ. Just right” perceptions associated with compulsive behavior in Tourette's syndrome. Am J Psychiatry 1994; 151: 675–680
   PubMed Web of Science ®Google Scholar
• Leckman JF, Grice DE, Barr LC, et al. Tic-related vs. non-tic related obsessive-compulsive disorder. Anxiety 1995; 1: 208–215
   Google Scholar
• Pitman RK. Pierre Janet on obsessive-compulsive disorder 1903. Review and commentary. Arch Gen Psychiatry 1987; 44: 226–232
   PubMed Web of Science ®Google Scholar
• Miguel EC, do Rosario-Campos MC, da Silva Prado H, et al. Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry 2000; 61: 150–156
   PubMed Web of Science ®Google Scholar
• Coles ME, Frost RO, Heimberg RG, Rhéaume J. Not just right experiences”: perfectionism, obsessive-compulsive features and general psychopathology. Behav Res Ther 2003; 41: 681–700
   PubMed Web of Science ®Google Scholar
• Summerfeldt LJ. Understanding and treating incompleteness in obsessive-compulsive disorder. J Clin Psychol 2004; 60: 1155–1168
   PubMed Web of Science ®Google Scholar
• McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000; 57: 794–801
   PubMed Web of Science ®Google Scholar
• Azrin NH, Nunn RG. Habit reversal: a method for eliminating nervous habits and tics. Behav Res Ther 1973; 11: 619–628
   PubMed Web of Science ®Google Scholar
• Baer L, Rauch SL, Ballantine HT, et al. Cingulotomy for intractable obsessive-compulsive disorder: prospective long-term follow-up of 18 patients. Arch Gen Psychiatry 1995; 52: 384–392
   PubMed Web of Science ®Google Scholar
• Tsao S, McKay D. Behavioral avoidance tests and disgust in contamination fear: distinctions from trait anxiety. Behav Res Ther 2004; 42: 207–216
   PubMed Web of Science ®Google Scholar
• McKay D. Treating disgust reactions in contamination-based obsessive-compulsive disorder. J Behav Ther Exp Psychiatry 2006; 37: 53–59
   PubMed Web of Science ®Google Scholar
• Jones MK, Menzies RG. Danger ideation reduction therapy (DIRT) for obsessive-compulsive washers: a controlled trial. Behav Res Ther 1998; 36: 959–970
   PubMed Web of Science ®Google Scholar
• Krochmalik A, Jones MK, Menzies RG. Danger Ideation Reduction Therapy (DIRT) for treatment-resistant compulsive washing. Behav Res Ther 2001; 39: 897–912
   PubMed Web of Science ®Google Scholar
• Denys D, de Geus F, van Megen HJGM, Westenberg HGM. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry 2004; 65: 1040–1048
   PubMed Web of Science ®Google Scholar
• Greist JH. An integrated approach to treatment of obsessive-compulsive disorder. J Clin Psychiatry 1992; 53(Suppl)38–41
   PubMed Web of Science ®Google Scholar
• Rachman SJ, Hodgson RJ. Obsessions and compulsions. Prentice Hall, New York 1980
   Google Scholar
• Foa EB, Steketee GS, Ozarow BJ. Behavior therapy with obsessive compulsives: from theory to treatment. Obsessive compulsive disorder: psychological and pharmacological treatments, M Mavissakalian, SM Turner, L Michelson. Plenum Press, New York 1985; 49–129
   Google Scholar
• Fisher PL, Wells A. How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis. Behav Res Ther 2005; 43: 1543–1558
   PubMed Web of Science ®Google Scholar
• Salkovskis PM. Obsessional–compulsive problems: a cognitive-behavioural analysis. Behav Res Ther 1985; 23: 571–583
   PubMed Web of Science ®Google Scholar
• Rachman S. A cognitive theory of compulsive checking. Behav Res Ther 2002; 40: 625–639
   PubMed Web of Science ®Google Scholar
• Tolin DF, Abramowitz JS, Brigidi BD, Foa EB. Intolerance of uncertainty in obsessive-compulsive disorder. J Anxiety Disord 2003; 17: 233–242
   PubMed Web of Science ®Google Scholar
• van den Hout M, Kindt M. Repeated checking causes memory distrust. Behav Res Ther 2003; 41: 301–316
   PubMed Web of Science ®Google Scholar
• Clark DA. Lumping versus splitting: a commentary on subtyping in OCD. Behav Ther 2005; 36: 401–404
   Web of Science ®Google Scholar
• Anholt GE, Kempe P, de Haan E, et al. Cognitive versus behavior therapy: processes of change in the treatment of obsessive-compulsive disorder. Psychother Psychosom 2008; 77: 38–42
   PubMed Web of Science ®Google Scholar
• Hofmann SG. Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders. Clin Psychol Rev 2008; 28: 200–211
   Web of Science ®Google Scholar